History 1 페이지
본문 바로가기
ENG
KOR
ENG
KOR
About
IMMUSE Therapeutics
History
History of IMMUSE Therapeutics
2024
Selected as Korea Drug Development Fund's(IMT-105)
2023
Selected as a Military Service Exception Designated Company
Nomination of JLABS(@Shanghai) residency
Establishing US corporation(IMMUSE Pharmaceuticals, Inc.)
2022
Pre-A Funding
Establishing R&D Center
Relocation of HQ (Seoul, Korea)
Certification of Venture Enterprise
2021
Angel Funding
Foundation (IMMUSE Therapeutics, Inc.)
go top